Page 63 - GPD-4-2
P. 63

Gene & Protein in Disease                                          X chromosome in sex-biased autoimmunity



            However, skewed (i.e., asymmetric) representation of a   Table 1. Female prevalence for a subset of systemic and
            parental, active X chromosome is commonly seen among   organ‑specific autoimmune diseases
            females,  particularly in  the aging  population. 25-27  Both           Female:   Category  References
            genetic and non-genetic factors can contribute to skewed                Male ratio
            XCI. 25,28  At present, the exact identity of these factors is not   Systemic conditions
            known. Skewed XCI impacts the somatic XCI mosaicism
            across cells and tissues. When restricted to certain immune   Sjögren’s syndrome  20:1  Systemic  63
            cell populations, skewed XCI could potentially modulate   Systemic lupus erythematosus  9:1  Systemic  9
            differences in X-linked gene expression between cells,   Takayasu’s arteritis  9:1  Vasculitis  144
            and  consequently,  impact  the  functions  of  the  immune   Systemic sclerosis  3:1  Systemic  145
            system. Skewed XCI also occurs in the presence of   Giant cell arteritis  3:1   Vasculitis  144
            X-linked mutations, as in the case of asymptomatic female   Rheumatoid arthritis  3:1  Systemic  146,147
            carriers of Wiskott-Aldrich syndrome where the wild-type   Organ-targeted conditions
            allele is preferentially expressed in hematopoietic cells.
                                                         29
            Crucially, the inactive X chromosome is not fully silent.   Hashimoto’s thyroiditis  4 – 10:1  Thyroid  10
            In humans, more than 20% of X-linked genes “escape”   Grave’s disease     4:1   Thyroid     148
            XCI and exhibit partial-to-complete expression from both   Multiple sclerosis  3:1  Neurological  149
            parental X chromosomes in a female somatic cell. 30-34  For
            genes regulating immune system functions, escape from   Among the upregulated genes, there are genes normally
            XCI might increase their functional dosage and underlie   subject to XCI, such as FOXP3 and IL2RG, but also known
            sex differences in immune phenotypes. 33,35,36  As discussed   escapees such as  KDM5C and  JPX.  As discussed later
                                                                                            41
            below, X-linked genes escaping XCI have been associated   in this review, multiple other X-linked loci have been
            with ADs.                                          significantly linked to SLE pathogenesis and susceptibility,
            3. Sex-biased ADs risk: A female-specific          such as Toll-like receptor 7 (TLR7), CXorf21, TMEM187,
            disadvantage                                       and IRAK1, which all escape XCI. By escaping XCI, these
                                                               genes may exhibit partial to complete biallelic X-linked
            Epidemiological and clinical data indicate that the female   expression in female’s immune cells, contributing to gender
            sex is at significantly higher risk for ADs compared to the   differences in risk of ADs. 32,33,35
            male sex (Table 1). In general, up to 80% of individuals with
            a clinical diagnosis of an ADs are women. In discussing   3.2. Sjogren’s syndrome (SS)
            the involvement of X-linked genes in ADs, we will focus   SS is a systemic, chronic ADs which primarily affects the
            on three prominent, sex-biased ADs: Systemic lupus   lacrimal and salivary exocrine glands. Compared to other
            erythematosus, Sjögren’s syndrome, and HT, all of which   ADs, SS is more frequently associated with multiple types
            show a prevalence reaching 80% in female patients.  of lymphomas. 43,44  As for other ADs, age is a risk factor,
                                                               with most SS patients being at least 40 years old. There is
            3.1. SLE
                                                               no approved therapy to cure SS. The determinants of SS
            SLE is an autoimmune, systemic disease. Up to 90%   remain under active investigation. While the presence of
            of diagnosed patients are female.  The female sex and   a concurrent ADs, such as SLE or rheumatoid arthritis,
                                        9
            karyotypes with extra X chromosomes are at higher risk   appears  to  boost  the  risk  of developing  SS, genetic
            of SLE. SLE is a highly heterogenous disease. Clinical   predisposition to SS is supported by cases of families
            manifestations  may  range  from  mild  mucocutaneous   with multiple affected members. 45-51  Genome-wide
            expressions to inflammatory involvements of the central   association analyses for primary SS uncovered consistent
            nervous system as well as multiple other organs. The   signal within  HLA genes, particularly at MHC Class  II
            exact  etiology  of  SLE remains not  well  understood.  At   locus HLA-DRB1 in the Caucasian population. 52,53  Larger
            molecular level, anti-nuclear autoantibodies and Type  I   studies, also including multiple ethnicities, provided
            interferon (IFN) activity are detected. Multiple anomalies   more detailed genetic associations at HLA Class II alleles
            of B- and T-cell activity have been characterized in SLE. 37-40    DRB1 × 03:01, but also HLA-DQA1 and HLA-DQB1. 54-57
            T-cells exhibit aberrant maintenance of XCI in individuals   Beyond MHC genes, other genes associated or potentially
            affected with SLE as well as in NZB/W F1 XX mice, which   associated with SS have been reported, including IFN
            develop a systemic, ADs highly similar to SLE.  Up to a   regulatory factor 5 (IRF5), 58,59  a transcription factor
                                                  41
            hundred X-linked genes are overexpressed in T-cells from   activating  IFNA/B regulated also by  TLR7-9; interleukin
            SLE patient, 41,42  presumably resulting from X-reactivation.   12A (IL12A),  a cytokine required for T-cell induction
                                                                          60

            Volume 4 Issue 2 (2025)                         3                               doi: 10.36922/gpd.8321
   58   59   60   61   62   63   64   65   66   67   68